HIV-1 infection cannot be cured as it persists in latently infected cells that are targeted neither by the immune system nor by available therapeutic approaches. Consequently, a lifelong therapy suppressing only the actively replicating virus is necessary. The latent reservoir has been defined and characterized in various experimental models and in human patients, allowing research and development of approaches targeting individual steps critical for HIV-1 latency establishment, maintenance, and reactivation. However, additional mechanisms and processes driving the remaining low-level HIV-1 replication in the presence of the suppressive therapy still remain to be identified and targeted. Current approaches toward HIV-1 cure involve namely attempts to reactivate and purge HIV latently infected cells (so-called "shock and kill" strategy), as well as approaches involving gene therapy and/or gene editing and stem cell transplantation aiming at generation of cells resistant to HIV-1. This review summarizes current views and concepts underlying different approaches aiming at functional or sterilizing cure of HIV-1 infection.

BIOCEV Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec Průmyslová 595 252 50 Vestec Czech Republic

Department of Immunology and Microbiology 1st Faculty of Medicine Charles University Studnickova 7 128 00 Prague 2 Czech Republic

Zobrazit více v PubMed

J Virol. 2006 Jan;80(2):854-65 PubMed

Cell Host Microbe. 2008 Aug 14;4(2):134-46 PubMed

Mol Cell Biol. 2003 Sep;23 (18):6618-30 PubMed

Cell Death Dis. 2013 Dec 05;4:e944 PubMed

Nat Med. 2009 Aug;15(8):893-900 PubMed

J Virol. 2012 Jan;86(1):630-4 PubMed

J Virol. 2011 Jun;85(12):6060-4 PubMed

J Clin Invest. 2009 Nov;119(11):3473-86 PubMed

Clin Infect Dis. 2014 Mar;58(6):883-90 PubMed

Science. 2004 Apr 2;304(5667):104-7 PubMed

Curr Opin HIV AIDS. 2016 Mar;11(2):234-41 PubMed

EMBO J. 1993 Aug;12(8):3249-59 PubMed

J Virol. 2015 Dec 09;90(4):1858-71 PubMed

AIDS Res Ther. 2009 Nov 05;6:23 PubMed

Nat Med. 2003 Jun;9(6):727-8 PubMed

Cell Cycle. 2013 Feb 1;12 (3):452-62 PubMed

Nature. 2014 Jan 23;505(7484):509-14 PubMed

Lancet Infect Dis. 2010 Jul;10(7):455-63 PubMed

Retrovirology. 2013 Feb 01;10:11 PubMed

Virology. 2013 Jan 20;435(2):329-40 PubMed

J Neurovirol. 2012 Oct;18(5):400-10 PubMed

J Virol. 2005 Jun;79(11):6610-9 PubMed

Lancet HIV. 2014 Oct;1(1):e13-21 PubMed

Virology. 2015 Nov;485:1-15 PubMed

J Clin Invest. 2016 Apr 1;126(4):1353-66 PubMed

J Virol. 2012 May;86(9):5390-2 PubMed

EBioMedicine. 2015 Jun 27;2(8):874-83 PubMed

J Virol. 2012 Jan;86(1):339-47 PubMed

PLoS Pathog. 2015 Nov 05;11(11):e1005233 PubMed

J Infect Dis. 2014 Sep 1;210(5):728-35 PubMed

PLoS Pathog. 2007 Oct 12;3(10):1459-69 PubMed

Nucleic Acids Res. 2012 Jan;40(1):414-27 PubMed

Antivir Chem Chemother. 2004 Jul;15(4):207-22 PubMed

EMBO J. 1993 Sep;12(9):3551-8 PubMed

Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12 PubMed

Curr Opin Virol. 2015 Aug;13:75-80 PubMed

Antiviral Res. 2011 Dec;92 (3):434-46 PubMed

Nature. 2006 Feb 16;439(7078):871-4 PubMed

J Virol. 2012 Dec;86(23 ):12552-60 PubMed

Cell Cycle. 2013 Feb 15;12(4):545-6 PubMed

Nat Med. 2014 Apr;20(4):425-9 PubMed

Nat Med. 1999 May;5(5):512-7 PubMed

MBio. 2015 Jul 07;6(4):e00465 PubMed

EMBO J. 1990 Apr;9(4):1157-64 PubMed

Nat Rev Immunol. 2014 Jan;14(1):24-35 PubMed

PLoS Pathog. 2011 Oct;7(10):e1002288 PubMed

J Virol. 2011 Jun;85(11):5384-93 PubMed

PLoS Pathog. 2015 Sep 17;11(9):e1005142 PubMed

Nat Med. 2007 Oct;13(10):1241-7 PubMed

Nature. 2015 Jun 25;522(7557):487-91 PubMed

J Clin Invest. 2007 Feb;117(2):473-81 PubMed

J Infect Dis. 2015 Nov 1;212(9):1361-5 PubMed

Nature. 2012 Jul 25;487(7408):482-5 PubMed

Methods Mol Biol. 2005;304:3-15 PubMed

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1692-4 PubMed

J Biol Chem. 2011 Jul 1;286(26):22758-68 PubMed

J Biol Chem. 2010 May 28;285(22):16538-45 PubMed

Clin Epigenetics. 2016 Feb 19;8:19 PubMed

Retrovirology. 2013 Apr 15;10:41 PubMed

Viruses. 2015 Jul 27;7(8):4186-203 PubMed

Science. 2014 Jun 20;344(6190):1392-6 PubMed

J Virol. 2013 Jun;87(11):6521-5 PubMed

Retrovirology. 2013 Oct 24;10:121 PubMed

Science. 1996 Mar 15;271(5255):1582-6 PubMed

Nature. 1995 Jan 12;373(6510):123-6 PubMed

Nat Med. 2015 Feb;21(2):132-9 PubMed

Cell. 2013 Oct 24;155(3):540-51 PubMed

EMBO J. 2007 Jan 24;26(2):412-23 PubMed

Bioessays. 2013 Jun;35(6):544-52 PubMed

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6321-6 PubMed

Nature. 1990 May 24;345(6273):356-9 PubMed

Front Immunol. 2016 Jan 28;7:12 PubMed

J Virol. 2004 Sep;78(17):9105-14 PubMed

J Clin Microbiol. 2008 Jul;46(7):2206-11 PubMed

PLoS Pathog. 2007 Apr;3(4):e46 PubMed

J Mol Biol. 2011 Jul 29;410(5):896-916 PubMed

Mol Cell Biol. 2000 Apr;20(8):2629-34 PubMed

PLoS Pathog. 2015 Jul 30;11(7):e1005066 PubMed

J Virol. 1997 Mar;71(3):2233-40 PubMed

Science. 2014 Jan 24;343(6169):428-32 PubMed

Nat Genet. 2008 Apr;40(4):466-70 PubMed

J Immunol. 1989 Jan 15;142(2):431-8 PubMed

Science. 2013 Aug 23;341(6148):903-6 PubMed

Trends Microbiol. 2015 Apr;23(4):192-203 PubMed

Nature. 1989 Jun 1;339(6223):389-92 PubMed

PLoS One. 2014 Jan 21;9(1):e85999 PubMed

J Virol. 2009 May;83(10):4749-56 PubMed

Cell. 2005 Jul 29;122(2):169-82 PubMed

Clin Exp Immunol. 2014 Jun;176(3):401-9 PubMed

BMC Mol Biol. 2007 Jul 30;8:63 PubMed

J Exp Med. 1998 Jun 15;187(12):2031-6 PubMed

Immunology. 2010 May;130(1):1-9 PubMed

Free Radic Biol Med. 1995 Oct;19(4):523-8 PubMed

Blood. 2009 Jan 1;113(1):58-65 PubMed

Crit Rev Biochem Mol Biol. 2016;51(1):26-42 PubMed

Retrovirology. 2004 Dec 15;1:43 PubMed

Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1756-9 PubMed

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):10958-61 PubMed

Science. 2007 Mar 16;315(5818):1579-82 PubMed

J Clin Invest. 2016 Feb;126(2):464-72 PubMed

PLoS Pathog. 2014 Dec 11;10(12):e1004543 PubMed

Clin Epigenetics. 2015 Sep 24;7:103 PubMed

PLoS Pathog. 2009 Aug;5(8):e1000554 PubMed

PLoS One. 2010 Jun 16;5(6):e11160 PubMed

Hum Vaccin Immunother. 2013 May;9(5):993-1001 PubMed

PLoS One. 2012;7(1):e30176 PubMed

J Infect Dis. 2015 Nov 1;212(9):1387-96 PubMed

Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7175-80 PubMed

J Virol. 1995 Mar;69(3):1612-20 PubMed

Curr Opin Cell Biol. 2015 Dec;37:111-8 PubMed

Nat Rev Drug Discov. 2009 Dec;8(12):969-81 PubMed

PLoS One. 2013 Oct 30;8(10):e77749 PubMed

J Virol. 2014 Mar;88(6):3516-26 PubMed

Nat Med. 2010 Apr;16(4):446-51 PubMed

EMBO J. 2007 Dec 12;26(24):4985-95 PubMed

AIDS. 2013 Jan 14;27(2):F7-F11 PubMed

AIDS. 2011 Mar 27;25(6):741-9 PubMed

AIDS. 2011 Jul 17;25(11):1347-56 PubMed

Cell Host Microbe. 2013 Jun 12;13(6):625-6 PubMed

Nat Struct Biol. 2003 Oct;10(10):800-6 PubMed

PLoS One. 2015 Apr 13;10(4):e0119234 PubMed

Blood. 2001 Nov 15;98(10):3006-15 PubMed

Biochem Biophys Res Commun. 2008 Nov 7;376(1):180-5 PubMed

Nat Med. 2001 Apr;7(4):459-64 PubMed

Blood. 2013 Dec 12;122(25):4013-20 PubMed

Front Immunol. 2014 Feb 25;5:71 PubMed

Blood. 2007 Dec 15;110(13):4161-4 PubMed

PLoS Pathog. 2009 Jan;5(1):e1000263 PubMed

PLoS One. 2008 Oct 01;3(10):e3305 PubMed

PLoS Pathog. 2015 Oct 16;11(10):e1005201 PubMed

J Virol. 2012 Jan;86(1):114-20 PubMed

J Virus Erad. 2016 Jan 01;2(1):57-65 PubMed

Virology. 2014 Apr;454-455:328-39 PubMed

Nat Rev Microbiol. 2014 Nov;12(11):750-64 PubMed

Nature. 1987 Dec 3-9;330(6147):489-93 PubMed

J Biol Chem. 2014 Aug 22;289(34):23568-81 PubMed

PLoS Pathog. 2006 Jul;2(7):e68 PubMed

Science. 1997 Nov 14;278(5341):1295-300 PubMed

ILAR J. 2008;49(2):220-55 PubMed

Nature. 2016 Feb 4;530(7588):51-56 PubMed

Cancer Res. 2011 Jun 1;71(11):4028-39 PubMed

Nucleic Acids Res. 2011 Jul;39(13):5424-38 PubMed

AIDS Res Hum Retroviruses. 2016 Feb;32(2):120-4 PubMed

J Virol. 2001 Dec;75(23):11417-25 PubMed

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):278-82 PubMed

PLoS Pathog. 2009 Jun;5(6):e1000495 PubMed

J Virol. 2016 May 27;90(12 ):5643-56 PubMed

Nature. 2012 Jul 25;487(7408):439-40 PubMed

Immunol Lett. 2007 Jan 15;108(1):45-51 PubMed

Immunol Rev. 2013 Jan;251(1):160-76 PubMed

Nucleic Acids Res. 2012 Oct;40(18):9160-70 PubMed

Sci Rep. 2015 Jan 09;5:7701 PubMed

Proc Natl Acad Sci U S A. 2014 May 13;111(19):7078-83 PubMed

Molecules. 2015 Mar 02;20(3):3898-941 PubMed

Retrovirology. 2004 Dec 15;1:44 PubMed

Retrovirology. 2013 Jun 26;10:67 PubMed

J Exp Med. 2011 Nov 21;208(12):2497-510 PubMed

J Antimicrob Chemother. 2016 Jul;71(7):1954-65 PubMed

Cell Host Microbe. 2013 Jun 12;13(6):665-77 PubMed

PLoS Pathog. 2013;9(12):e1003834 PubMed

Nature. 1997 May 8;387(6629):188-91 PubMed

Cell. 2015 Jun 4;161(6):1293-1305 PubMed

Mol Cell. 2006 Jan 20;21(2):227-37 PubMed

Curr HIV/AIDS Rep. 2012 Mar;9(1):91-100 PubMed

Science. 1987 Nov 6;238(4828):800-2 PubMed

Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365-8 PubMed

J Exp Med. 1998 Jul 6;188(1):83-91 PubMed

Cell. 1998 Feb 20;92(4):451-62 PubMed

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84 PubMed

EMBO J. 2006 Jan 11;25(1):139-49 PubMed

J Virol. 2011 Sep;85(17 ):9078-89 PubMed

Nat Med. 2014 Feb;20(2):139-42 PubMed

J Infect Dis. 2010 Dec 1;202(11):1738-48 PubMed

Curr Opin HIV AIDS. 2016 Mar;11(2):201-8 PubMed

AIDS. 2014 Jul 17;28(11):1555-66 PubMed

J Virol. 2010 Jul;84(13):6425-37 PubMed

J Virol. 2001 May;75(10):4655-63 PubMed

Mol Cell Biol. 2002 May;22(9):2965-73 PubMed

J Infect Dis. 2013 Jun 1;207(11):1694-702 PubMed

J Clin Microbiol. 2003 Oct;41(10):4531-6 PubMed

EMBO J. 2003 Apr 15;22(8):1868-77 PubMed

EMBO J. 2007 Jan 24;26(2):424-35 PubMed

PLoS Pathog. 2006 Jun;2(6):e60 PubMed

J Virol. 2004 Oct;78(19):10507-15 PubMed

Nat Commun. 2015 Oct 20;6:8608 PubMed

Nature. 1995 Jan 12;373(6510):117-22 PubMed

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841 PubMed